Overview
Two lists matter here, and the second is longer and more often ignored.
Absolute contraindications are situations where testosterone should not be given. Situations requiring assessment or treatment first are where most inappropriate prescribing actually happens — not because someone was given a drug they must never have, but because they were given it before the thing that mattered was looked at.
| Should not have testosterone therapy |
|---|
| Active prostate cancer — a urology decision, not a general one |
| Male breast cancer |
| Pregnancy in a partner exposed to topical gel — transfer risk |
| Uncontrolled heart failure |
| Recent heart attack or stroke |
| A man actively trying to conceive — it suppresses sperm production |
| Hematocrit already above the action threshold — address that first |
| Needs assessing or treating first |
|---|
| Untreated sleep apnea — screen and treat, then reassess |
| Elevated PSA or an abnormal prostate exam — evaluate first |
| Significant obesity — it lowers testosterone and may be reversible |
| Opioid use — suppresses the axis directly; review it |
| Uncontrolled hypertension, especially if oral is being considered |
| A diagnosis made on one afternoon sample — repeat it properly |
The largest single category of men who should not be on testosterone is not on either list. It is men who do not have testosterone deficiency — diagnosed from a single low reading, without symptoms, without LH and FSH, and without anyone looking for a reversible cause.
The prostate question, stated accurately
This is the most misunderstood item, and the understanding has changed.
Active prostate cancer remains a situation where testosterone is not given outside specialist care. That is not controversial.
What has changed is the broader picture. For decades testosterone therapy was believed to cause prostate cancer. The evidence has not supported that, and current guidance from major urological bodies reflects a more nuanced position than the historical blanket prohibition — including that some men treated for prostate cancer may be candidates in specific circumstances, assessed by their urologist.
What has not changed is the monitoring. PSA and a prostate assessment before starting, and monitoring afterwards, because testosterone can raise PSA and because finding an existing cancer before treatment matters.
A raised PSA or an abnormal examination is a reason to evaluate before starting, not a reason to be permanently excluded.
Men with a history of prostate cancer: this is a conversation with your urologist, not a general question.
Hematocrit, which is the commonest real barrier
More men are appropriately declined or paused for this than for anything else on either list.
Testosterone stimulates red cell production. A man whose hematocrit is already above the action threshold should have that addressed before starting rather than after — and the cause is worth finding, because sleep apnea, smoking and dehydration are all common contributors.
On treatment, a hematocrit that keeps climbing is the most frequent reason a regimen has to change or stop. Why it is the number that matters.
Fertility, which is a decision rather than a contraindication
Testosterone therapy suppresses sperm production, frequently to zero. For a man actively trying to conceive, that makes it inappropriate.
For a man who may want children later, it is not a prohibition — it is a decision that should be made with the information, before the first prescription, and with sperm banking discussed. Recovery after stopping is usual, takes six to twelve months or longer, and is not guaranteed.
This is the single most under-communicated fact in the testosterone market. The full picture.
Sleep apnea, which is a sequencing problem
Untreated sleep apnea appears on the second list rather than the first for a specific reason: it may be the cause.
Apnea suppresses testosterone. Testosterone can worsen apnea. Both raise hematocrit. Treating the apnea sometimes resolves the testosterone question entirely.
So the right order is screen, refer, treat, then reassess — rather than treat the number and leave the apnea in place. Why this is the biggest miss in the TRT line.
The category nobody puts on a contraindication list
Worth stating plainly, because it is the largest group.
Men who do not have testosterone deficiency should not be on testosterone therapy. Not because it is dangerous for them specifically, but because they are accepting real consequences — fertility suppression, hematocrit monitoring, an indefinite commitment, and a suppressed axis — for a condition they do not have.
The diagnosis requires consistently low levels on at least two morning samples, plus symptoms. Not one afternoon reading. Not a level in the lower half of the range. Not age alone.
And it requires looking for the reversible causes first: obesity, sleep apnea, opioids, alcohol, thyroid disease, raised prolactin, significant illness. Several of those are treatable in their own right.
Testosterone products are also not indicated for age-related decline without an identified cause, and the labeling says so — a distinction widely ignored in the direct-to-consumer market. What the assessment should cover.
What else should be checked before starting
Two morning testosterone samples, fasting, not during illness.
SHBG, so free testosterone can be estimated.
LH and FSH, which separate a testicular cause from a pituitary one and change what treatment makes sense.
Prolactin where LH is low.
Baseline hematocrit and PSA.
Blood pressure, especially if an oral formulation is being considered, which carries a boxed warning for it. More.
A sleep apnea screen.
And the fertility conversation.
If a provider is prescribing without most of that, the gap is the assessment rather than the drug.
Frequently asked questions
Who should not take testosterone therapy? Men with active prostate cancer or male breast cancer, men with uncontrolled heart failure or a recent heart attack or stroke, men actively trying to conceive, and men whose hematocrit is already above the action threshold.
Does testosterone cause prostate cancer? The evidence has not supported that, and current guidance reflects a more nuanced position than the historical prohibition. Active prostate cancer remains a specialist situation, and PSA monitoring is part of standard care.
What if I have sleep apnea? Screen, refer and treat it first, then reassess. Apnea suppresses testosterone and testosterone can worsen apnea, so the order matters.
What if I want children? Testosterone suppresses sperm production, often to zero. For a man actively trying to conceive it is inappropriate; for a man who may want children later it is a decision to make before starting, with sperm banking discussed.
What if my level is only slightly low? A single low reading is not a diagnosis. It requires two morning samples plus symptoms, and a search for reversible causes before anything is prescribed.
Where this fits in your plan
The most common reason a man should not be on testosterone is that he does not have testosterone deficiency — and that is established by a proper assessment rather than by a single number.
If you are on treatment and unsure whether that assessment ever happened, it is worth doing now. What we check.
We measure first. Then we act.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
